When the Steppenwolf Theatre Company gathered its founding ensemble in a Highland Park basement in 1976, they were making an artistic and economic bet that has shaped American theater ever since. The bet was that long-term collaboration among the same group of actors would produce work no freelance assembly could match—and that audiences and funders would reward that distinctiveness sufficiently to sustain the model.

Nearly five decades later, that bet looks increasingly precarious. The American resident company model, once the assumed structure for serious theatrical work outside Broadway, has contracted dramatically. Even institutions that retain the company name often operate as essentially freelance houses with a handful of associated artists on retainer.

Yet the question of whether to maintain a resident ensemble remains one of the most consequential decisions any producing theater faces. It touches every dimension of organizational life: programming possibilities, audience identity, fundraising narrative, labor relationships, and the kind of artistic risk the institution can credibly undertake. Understanding the actual tradeoffs—rather than the romanticized versions on either side—requires examining how each model functions when operating well and when operating poorly, and what hybrid structures have emerged to address the limitations of both.

Resident companies generate a specific kind of artistic capital that is genuinely difficult to manufacture through other means. When actors have worked together across multiple productions over years, they develop a shared physical vocabulary, an instinct for each other's rhythms, and a trust that permits genuine risk in rehearsal. Directors working with established ensembles can begin substantive work on day one rather than spending the first week of a five-week rehearsal process establishing basic communication protocols.

This advantage compounds particularly for difficult repertoire. Chekhov, Brecht, devised work, and physically demanding ensemble pieces all benefit enormously from collective history. Théâtre du Soleil's decades-long collaborations under Ariane Mnouchkine produce work that would be structurally impossible with freelance casting—not merely better, but categorically different.

The constraints, however, are equally real. A resident company of twelve actors can effectively cast perhaps thirty to forty percent of the existing dramatic literature without significant compromise. The remaining repertoire requires either supplementary hiring, type-stretched casting that diminishes the work, or simply being avoided. Companies committed to ensemble identity often find themselves choosing plays that fit their members rather than choosing members who can serve their artistic ambitions.

Freelance models invert this calculus. Each production assembles the ideal cast for that specific script, with directors selecting from a continental talent pool. New play development particularly benefits, since playwrights need not write to existing company strengths. The cost is the loss of ensemble depth that even excellent freelance casts rarely achieve in standard rehearsal periods.

What gets lost in most discussions is that these models produce different art, not better or worse art. A theatrical culture containing only one approach impoverishes the form's expressive range, regardless of which model dominates.

Takeaway

The choice between ensemble and freelance casting is not a choice between artistic excellence and compromise—it is a choice about which kinds of theatrical excellence the institution will pursue and which it will forgo.

Comparisons between resident company and freelance models routinely understate the true cost differential, typically because hidden expenses on both sides escape the analysis. A serious accounting reveals a more complicated picture than either advocates or critics usually present.

Resident company costs extend well beyond annual salaries. Health insurance, retirement contributions, payroll taxes, and workers' compensation typically add thirty to forty percent above base compensation. Then come the structural costs: rehearsal and development time during which company members are paid but not generating ticket revenue, ongoing training and voice work, the administrative overhead of managing year-round employment relationships, and the productivity loss when company members are unavailable for certain projects due to physical type or scheduling.

Freelance hiring carries its own concealed costs that institutions often overlook in financial projections. Casting director fees, travel and housing for out-of-town hires, longer rehearsal periods to compensate for absent ensemble history, increased understudy costs given less coverage flexibility, and the marketing burden of building audience interest in unfamiliar faces each production. The recruitment overhead alone—maintaining relationships with agents, attending showcases, managing offer negotiations—consumes substantial artistic staff time.

There is also the question of what each model permits institutionally. Resident companies enable certain efficiencies that freelance operations cannot match: rapid program changes, cross-departmental contribution to education and outreach, institutional knowledge transfer, and reduced redundancy in onboarding processes. Conversely, freelance models offer fiscal flexibility during contractions that fixed company costs simply do not allow.

The honest conclusion is that neither model is reliably cheaper. They distribute costs differently across time and category, with implications for organizational risk tolerance and cash flow management that matter as much as the absolute totals.

Takeaway

Financial sustainability questions about company structure cannot be answered by spreadsheet alone—they depend on which risks the institution is structurally equipped to absorb and which would prove fatal.

Most American theaters that retain ensemble identity now operate hybrid structures, and examining how these arrangements actually function reveals both their promise and their characteristic failure modes. The intermediate models proliferate because they attempt to capture ensemble benefits without absorbing full company costs—a worthwhile aspiration that requires honest design.

The associate artist model, used by institutions from the Wooster Group to numerous regional theaters, names a stable pool of returning collaborators without guaranteeing employment or providing benefits. Done well, it creates predictable artistic relationships while preserving fiscal flexibility. Done poorly, it offers institutions the marketing benefits of ensemble identity while transferring all the risk of inconsistent work to artists who structure their careers around unreliable promises.

Season-long companies, where a group of actors is contracted for an entire programming year across multiple productions, occupy another intermediate position. Steppenwolf's mainstage seasons, certain Shakespeare festivals, and repertory operations like Pearl Theatre employed variations on this approach. The artistic benefits are substantial within the season, but ensemble depth that accumulates over years cannot develop within months, and the model places significant casting constraints on each production within the contract period.

More radical experiments include project-based ensembles formed for specific multi-year initiatives, shared company arrangements where multiple institutions collaboratively employ artists across geographies, and cooperative structures where actors collectively own production entities. Each addresses particular limitations of conventional models while introducing new coordination challenges.

The pattern across successful hybrids is alignment between stated structure and actual practice. Institutions get into trouble when they market ensemble identity to audiences and funders while operating essentially as freelance houses, creating expectations the work cannot meet and obligations to artists the budget cannot fulfill.

Takeaway

Hybrid structures succeed when they are honest about what they actually provide; they fail when they borrow the language of ensemble commitment without accepting its underlying obligations.

The resident company question rarely admits of a clean answer, and institutions that present their structural choice as obvious have usually stopped examining it carefully. What the contraction of the American company model has obscured is that this was always a choice about institutional identity rather than operational efficiency.

The healthier framing asks what kind of work the institution exists to make, what relationship with artists serves that work, and what financial structure can sustain those commitments through ordinary turbulence. Answers will differ legitimately across institutions, and a robust theatrical ecology benefits from genuine variety rather than convergence on a single dominant model.

What remains worth defending is the possibility itself. A field in which sustained ensemble work becomes structurally impossible has lost something specific and irreplaceable, regardless of what flourishes in its absence.